Natascha Rieder
Impact in
- Small Animals top 5%
- Infectious Diseases and Mycology
-
- Veterinary Oncology Research
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 4
- Peptidase Inhibition and Analysis 3
- CAR-T cell therapy research 2
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Anton Belousov (3 shared papers)Frédérique Nguyen (3 shared papers)Catherine Ibisch (3 shared papers)Mario Campone (2 shared papers)Jérôme Abadie (3 shared papers)L. Peña (2 shared papers)Delphine Loussouarn (3 shared papers)Adelina Gama (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Cancer Research (2 papers)Breast Cancer Research and Treatment (2 papers)PLoS ONE (1 paper)Molecular Oncology (1 paper)
- Partner nations
- SwitzerlandGermanyFrance
In The Last Decade
Natascha Rieder
16 papers receiving 359 citations
Peers
Comparison fields: 5 of 56
- Small Animals 67
- Pulmonary and Respiratory Medicine 163
- Oncology 138
- Immunology 83
- Pathology and Forensic Medicine 41
Countries citing papers authored by Natascha Rieder
This map shows the geographic impact of Natascha Rieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natascha Rieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natascha Rieder more than expected).
Fields of papers citing papers by Natascha Rieder
This network shows the impact of papers produced by Natascha Rieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natascha Rieder. The network helps show where Natascha Rieder may publish in the future.
Co-authors
The 25 scholars most cited alongside Natascha Rieder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 102 | |
| 2 | 2017 | 88 | |
| 3 | 2013 | 39 | |
| 4 | 2021 | 29 | |
| 5 | 2016 | 28 | |
| 6 | 2013 | 26 | |
| 7 | 2019 | 17 | |
| 8 | 2017 | 10 | |
| 9 | 2024 | 10 | |
| 10 | 2015 | 7 | |
| 11 | 2023 | 4 | |
| 12 | 2018 | 4 | |
| 13 | 2024 | 2 | |
| 14 | [Fall/winter depression and its therapy]. | 1994 | 2 |
| 15 | 2011 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2011 | 0 | |
| 18 | 2025 | 0 |
About Natascha Rieder
Natascha Rieder is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 370 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Veterinary Oncology Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Glycosylation and Glycoproteins Research (2 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers) and Advanced Proteomics Techniques and Applications (1 paper). The work is most often cited by research in Small Animals (67 citations), Pulmonary and Respiratory Medicine (163 citations), Oncology (138 citations), Immunology (83 citations) and Pathology and Forensic Medicine (41 citations). Natascha Rieder has collaborated with scholars based in Switzerland, Germany and France. Frequent co-authors include Anton Belousov, Frédérique Nguyen, Catherine Ibisch, Mario Campone, Jérôme Abadie, L. Peña, Delphine Loussouarn, Adelina Gama, Thomas Friess and Sabine Bader. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Breast Cancer Research and Treatment, PLoS ONE and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.